Expansion of Pakistan’s Immunisation Programme
The District Health Authority (DHA) Rawalpindi has announced a significant expansion of the national immunisation programme, adding cervical cancer as the thirteenth disease on the list of life-saving vaccines. This move places the HPV vaccine alongside well-established protections against diseases such as tuberculosis, measles, polio, and hepatitis B, reinforcing the district’s commitment to safeguarding the health of its young population.
Targeting Nine-Year-Old Girls
Starting in February 2026, the HPV vaccination drive will be administered exclusively to nine-year-old girls. The DHA says this age-specific approach is designed to provide early and lasting protection before potential exposure to the virus that causes cervical cancer. Officials emphasise that vaccinating at this age helps maximise vaccine effectiveness and long-term health outcomes for girls in Rawalpindi.
Progress of the Expanded Campaign
Earlier this year, a broader HPV vaccination campaign ran from September 15 to 27, targeting girls aged nine to 14. The drive achieved 94 percent of its target, reflecting strong community engagement and trust in the immunisation program. Building on this momentum, health authorities will now shift to a year-long, continuous vaccination cycle focused on younger participants.
Why Cervical Cancer Vaccination Matters
Cervical cancer remains a critical health concern for women globally. Vaccinating against human papillomavirus (HPV) is one of the most effective strategies to reduce the risk of developing cervical cancer later in life. By including HPV vaccination in the national programme and aligning it with other essential vaccines, Pakistan aims to reduce mortality and improve long-term health outcomes for its female population.
Implementation Details and Oversight
Dr Ehsan Ghani, the DHA chief executive officer, told The Express Tribune that the integrated campaign will begin in February 2026 and run throughout the year. The plan calls for a coordinated effort across health facilities, schools, and community outreach programs to ensure high uptake among eligible girls. Officials emphasise the importance of information campaigns to address concerns, dispel myths, and encourage participation from communities across Rawalpindi.
Public Health Implications
Introducing the HPV vaccine to nine-year-old girls aligns with global best practices for cancer prevention. The strategy is anticipated to contribute to lower cervical cancer incidence in the coming decades, as more individuals gain protection from an early age. While the immediate impact is vaccination coverage, long-term benefits include reduced treatment costs, improved quality of life for women, and strengthened resilience of the public health system.
Community Response and Next Steps
Health authorities are urging parents and guardians to participate in the programme, attend vaccination sessions, and keep track of immunisation records. The DHA notes that successful rollout depends on sustained community engagement, accurate record-keeping, and ongoing monitoring of vaccine uptake. As the campaign progresses, updates will be provided through official channels to ensure transparency and accountability in the rollout process.
